Cited by 1,509Chemotherapy-induced cardiotoxicity and mitigationBioactive Compounds and Antitumor AgentsCancer therapeutics and mechanisms

The DOI matches its Crossref record.

Doxorubicin: The Good, the Bad and the Ugly Effect

Carvalho, Cristina, Santos, Renato, Cardoso, Susana, Correia, Sonia, Oliveira, Paulo, Santos, Maria, Moreira, Paula·2009·Current Medicinal Chemistry

DOI 10.2174/092986709788803312

Open this paper in CoChat — free account

Abstract

The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in fighting a wide range of cancers such as carcinomas, sarcomas and hematological cancers. Despite extensive clinical utilization, the mechanisms of action of DOX remain under intense debate. A growing body of evidence supports the view that this drug can be a double-edge sword. Indeed, injury to nontargeted tissues often complicates cancer treatment by limiting therapeutic dosages of DOX and diminishing the quality of patients' life during and after DOX treatment. The literature shows that the heart is a preferential target of DOX toxicity. However, this anticancer drug also affects other organs like the brain, kidney and liver. This review is mainly devoted to discuss the mechanisms underlying not only DOX beneficial effects but also its toxic outcomes. Additionally, clinical studies focusing the therapeutic efficacy and side effects of DOX treatment will be discussed. Finally, some potential strategies to attenuate DOX-induced toxicity will be debated.

Integrity signals

Registry

Crossref · 10.2174/092986709788803312

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 101–200 of 1,000

Intracellular cascade activated nanosystem for improving ER+ breast cancer therapy through attacking GSH-mediated metabolic vulnerability
Xiong, H., Wang, C., Wang, Z., Jiang, Z., Zhou, J., & Yao, J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.029 · Cited by 100
Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines
Kapadia, G. J., Rao, G. S., Ramachandran, C., Iida, A., Suzuki, N., & Tokuda, H. (2013) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2013-0007 · Cited by 100
“However, there are serious side-effects associated with the use of this potent anticancer drug [23].”
Background
Fabrication of BSA@AuNC-Based Nanostructures for Cell Fluoresce Imaging and Target Drug Delivery
Ding, C., Xu, Y., Zhao, Y., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b18493 · Cited by 99
Quercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin.
Atashpour, S., Fouladdel, S., Movahhed, T. K., Barzegar, E., Ghahremani, M. H., Ostad, S. N., & Azizi, E. (2015) · Europe PMC (PubMed Central) · Cited by 96
Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis
Eide, S., & Feng, Z. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173078 · Cited by 98
Bacteria as a treasure house of secondary metabolites with anticancer potential
Mohan, C. D., Rangappa, S., Nayak, S. C., Jadimurthy, R., Wang, L., Sethi, G., Garg, M., & Rangappa, K. S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.006 · Cited by 104
Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats
Kwatra, M., Kumar, V., Jangra, A., Mishra, M., Ahmed, S., Ghosh, P., Vohora, D., & Khanam, R. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1070879 · Cited by 97
“Doxorubicin (Dox) is a highly effective antineoplastic agent that is used to treat cancers of several tissues including hematological malignancies and soft-tissue sarcomas (Carvalho et al., 2009).”
Background
Echinochrome A Protects Mitochondrial Function in Cardiomyocytes against Cardiotoxic Drugs
Jeong, S., Kim, H. K., Song, I.-S., Lee, S., Ko, K. S., Rhee, B. D., Kim, N., Mishchenko, N. P., Fedoryev, S., Stonik, V. A., et al. (2014) · Marine Drugs · doi:10.3390/md12052922 · Cited by 96
“Thus, the clinical application of these drugs is limited due to their serious cardiotoxicity, which results in the permanent loss of cardiomyocytes [18].”
Background
Advances in aptamer-mediated targeted delivery system for cancer treatment
He, S., Du, Y., Tao, H., & Duan, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124173 · Cited by 99
Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy
Cai, D., Gao, W., He, B., Dai, W., Zhang, H., Wang, X., Wang, J., Zhang, X., & Zhang, Q. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.088 · Cited by 95
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
El-Agamy, S. E., Abdel‐Aziz, A. K., Esmat, A., & Azab, S. S. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03827-0 · Cited by 101
Exosomes and Cell Communication: From Tumour-Derived Exosomes and Their Role in Tumour Progression to the Use of Exosomal Cargo for Cancer Treatment
Nicolini, A., Ferrari, P., & Biava, P. M. (2021) · Cancers · doi:10.3390/cancers13040822 · Cited by 98
MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1
Zhao, X., Jin, Y., Li, L., Xu, L., Tang, Z., Qi, Y., Yin, L., & Peng, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104276 · Cited by 92
Bio-functionalized CuO nanoparticles induced apoptotic activities in human breast carcinoma cells and toxicity against Aspergillus flavus: An in vitro approach
Ali, K., Saquib, Q., Ahmed, B., Siddiqui, M. A., Ahmad, J., Al‐Shaeri, M., Al-Khedhairy, A. A., & Musarrat, J. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.01.008 · Cited by 92
Metabolic Aspects of Anthracycline Cardiotoxicity
Russo, M., Sala, A. D., Tocchetti, C. G., Porporato, P. E., & Ghigo, A. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-00812-1 · Cited by 95
“Doxorubicin (DOXO) is a highly effective chemotherapeutic drug belonging to non-selective class I anthracycline family [1], widely used for the treatment of several cancers, such as solid tumors, acute leukemia, lymphomas, and breast cancer [2, 3].”
Background
Cancer Nanomedicine: A New Era of Successful Targeted Therapy
El-Readi, M. Z., & Althubiti, M. (2019) · Journal of Nanomaterials · doi:10.1155/2019/4927312 · Cited by 92
“FDA has considered doxorubicin as one of the most effective chemotherapeutic drugs [98].”
Background
Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery
Escoffre, J., Mannaris, C., Geers, B., Novell, A., Lentacker, I., Averkiou, M. A., & Bouakaz, A. (2012) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2013.2539 · Cited by 90
“Because of its broad spectrum of activity, it is widely used for the treatment of solid tumors and hematological malignancies [1].”
BackgroundInfluential
Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo
Yang, R., Tang, Q., An, Y., Miao, F., Liu, P., & Li, M. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s67210 · Cited by 90
Microfluidic cell isolation technology for drug testing of single tumor cells and their clusters
Bithi, S. S., & Vanapalli, S. A. (2017) · Scientific Reports · doi:10.1038/srep41707 · Cited by 91
Bibliometric Analysis of Global Research Trends on Ultrasound Microbubble: A Quickly Developing Field
Wu, H., Tong, L., Wang, Y., Yan, H., & Sun, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.646626 · Cited by 90
Possibilities to increase the effectiveness of doxorubicin in cancer cells killing
Hanušová, V., Boušová, I., & Skálová, L. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.609174 · Cited by 89
“Cancer cell mortality could be increased with both dose and exposure time, but DOX systemic toxicity, especially cardiotoxicity, strongly limits the maximal therapeutic dose of DOX (Carvalho et al., 2009).”
BackgroundInfluential
Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
Zhao, X., Tian, Z., Sun, M., & Dong, D. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01565-0 · Cited by 94
“According to published studies, however, long-term administration of doxorubicin can cause severe damage to numerous organs in the body, with the heart being the primary target of doxorubicin toxicity [1, 2].”
Background
Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1
Zhu, J. Y., Zhang, R., Yang, D., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495168 · Cited by 87
Retracted
Pulmonary Targeting Crosslinked Cyclodextrin Metal–Organic Frameworks for Lung Cancer Therapy
He, Y., Xiong, T., He, S., Sun, H., Huang, C., Ren, X., Wu, L., Patterson, L. H., & Zhang, J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004550 · Cited by 87
Nanomaterial‐Based Organelles Protect Normal Cells against Chemotherapy‐Induced Cytotoxicity
Zhao, R., Liu, X., Yang, X., Jin, B., Shao, C., Kang, W., & Tang, R. (2018) · Advanced Materials · doi:10.1002/adma.201801304 · Cited by 85
Advances and trends of hydrogel therapy platform in localized tumor treatment: A review
Tan, B., Huang, L., Wu, Y., & Liao, J. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37062 · Cited by 85
Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells
Holmgren, G., Synnergren, J., Bogestål, Y. R., Améen, C., Åkesson, K., Holmgren, S., Lindahl, A. H., & Sartipy, P. (2014) · Toxicology · doi:10.1016/j.tox.2014.12.018 · Cited by 86
“is exponentially dose-dependant (Carvalho et al., 2009) and categorized as acute, early, or late (Zhang et al.”
Background
Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity
Khaleel, S. A., Al-Abd, A. M., Ali, A. A., & Abdel‐Naim, A. B. (2016) · Scientific Reports · doi:10.1038/srep36855 · Cited by 87
Nuciferine, extracted from Nelumbo nucifera Gaertn, inhibits tumor-promoting effect of nicotine involving Wnt/β-catenin signaling in non-small cell lung cancer
Liu, W., Yi, D., Guo, J., et al. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.02.015 · Cited by 85
Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway
Zhang, Y., Ahmad, K. A., Khan, F. U., Yan, S., Ihsan, A. U., & Ding, Q. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.03.027 · Cited by 84
Aminated hollow mesoporous silica nanoparticles as an enhanced loading and sustained releasing carrier for doxorubicin delivery
Nguyen, T. N. T., Le, N. T. T., Nguyen, N. H., et al. (2020) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2020.110543 · Cited by 83
A pH-sensitive charge-conversion system for doxorubicin delivery
Guan, X., Li, Y., Jiao, Z., Chen, J., Guo, Z., Tian, H., & Chen, X. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.04.047 · Cited by 83
Induction of apoptosis and cell cycle arrest by pericarp polyphenol-rich extract of Baneh in human colon carcinoma HT29 cells
Rezaei, P. F., Fouladdel, S., Hassani, S., Yousefbeyk, F., Ghaffari, S. M., Amin, G., & Azizi, E. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.11.012 · Cited by 83
“The main anticancer effect of Dox is due to DNA damage through topoisomerase II inhibition and free radical generation resulting in growth arrest or cell death (Carvalho et al., 2009; Grzanka et al., 2010).”
Background
Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro
Su, Z., Ye, J., Qin, Z., & Ding, X. (2015) · Scientific Reports · doi:10.1038/srep18314 · Cited by 83
Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin
Gallo, E., Diaferia, C., Rosa, E., Smaldone, G., Morelli, G., & Accardo, A. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s296272 · Cited by 83
Luteolin attenuates doxorubicin-induced derangements of liver and kidney by reducing oxidative and inflammatory stress to suppress apoptosis
Owumi, S. E., Lewu, D., Arunsi, U. O., & Oyelere, A. K. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211006171 · Cited by 81
“hepatic, cardiac, haematologic, and reproductive organs, and this often limits its therapeutic dosages.(15) DOX has been observed to induce hepatocyte damage by cell cycle arrest,(16) thus inhibiting the self-regeneration potential of the liver.”
Background
Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer
Lee, A., Choi, Y. J., Jeong, M. S., Park, Y. I., Motoyama, K., Kim, M. W., Kwon, S., & Choi, J. H. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00048 · Cited by 82
Injectable Carbon Nanotube Impregnated Silk Based Multifunctional Hydrogel for Localized Targeted and On-Demand Anticancer Drug Delivery
Gangrade, A., & Mandal, B. B. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00416 · Cited by 80
Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy
Guo, W., Song, Y., Song, W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64828-1 · Cited by 80
Conjugates of Porphyrinoid-Based Photosensitizers with Cytotoxic Drugs: Current Progress and Future Directions toward Selective Photodynamic Therapy
Otvagin, V. F., Kuzmina, N. S., Kudriashova, E. S., Nyuchev, A. V., Gavryushin, A. E., & Fedorov, A. Y. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01953 · Cited by 83
MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
Fan, Y.-P., Liao, J., Lu, Y., Tian, D., Ye, F., Zhao, P., Xiang, G., Tang, W.-X., & He, X. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.03.010 · Cited by 80
“Doxorubicin held promise as a powerful drug in the fight against a broad variety of solid and hematologic neoplasms and has been regarded as one of the most potent of the FDA-approved chemotherapeutic drugs.(3,4) Despite doxorubicin (DOX) playing an undisputed key role in transcatheter arterial chemoembolization (TACE…”
Background
GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress
Wang, Y., Lei, T., Yuan, J.-T., Wu, Y., Shen, X., Gao, J., Feng, W. H., & Lu, Z. (2018) · Redox Biology · doi:10.1016/j.redox.2018.04.009 · Cited by 80
Theranostic applications of selenium nanomedicines against lung cancer
Liu, S., Wei, W., Wang, J., & Chen, T. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01825-2 · Cited by 82
“the anticancer efficacy of DOX is not optimal because of its lack of targeted specificity, poor solubility, inadequate drug accumulation in the tumor, and serious side effects [255].”
Background
Co-delivery of doxorubicin and DNAzyme using ZnO@polydopamine core-shell nanocomposites for chemo/gene/photothermal therapy
Liu, M., Peng, Y., Nie, Y., Liu, P., Hu, S., Ding, J., & Zhou, W. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.041 · Cited by 79
Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1/Nrf2/NF-κB/TNF-α signaling pathways
Botros, S. R., Matouk, A. I., Amin, A., & Heeba, G. H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1353029 · Cited by 79
“The exact mechanism responsible for DOX-induced renal damage is not fully understood; however, many studies have emphasized the role of oxidative imbalance in DOX-induced nephrotoxicity (Deman et al., 2001; Lebrecht et al., 2004; Carvalho, et al., 2009; Afsar et al., 2020).”
Background
Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts
Coelho, A. R., Martins, T. R., Couto, R., Deus, C. M., Pereira, C. V., Simões, R. F., Rizvanov, A. A., Silva, F. S. G., Cunha‐Oliveira, T., Oliveira, P. J., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.030 · Cited by 78
“The anthracycline Doxorubicin (DOX) is one of the most prescribed and effective anti-cancer agents [1,2].”
Self-citation
Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer
Siminzar, P., Omidi, Y., Golchin, A., et al. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1616745 · Cited by 77
Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
Refaie, M. M. M., Amin, E. F., El‐Tahawy, N. F. G., et al. (2016) · Journal of Toxicology · doi:10.1155/2016/9507563 · Cited by 77
One-Step Self-Assembly of Multifunctional DNA Nanohydrogels: An Enhanced and Harmless Strategy for Guiding Combined Antitumor Therapy
Wei, H., Zhao, Z., Wang, Y., Zou, J., Lin, Q., & Duan, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15874 · Cited by 78
Antioxidant and Anti‐Inflammatory Effects of Crocin Ameliorate Doxorubicin‐Induced Nephrotoxicity in Rats
Hussain, M. A., Abogresha, N. M., Kader, G. A., Hassan, R., Abdelaziz‎, E. Z., & Greish, S. M. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8841726 · Cited by 79
“The antitumor activity of doxorubicin is attributed to its ability to intercalate into the DNA helix and/or bind covalently to proteins involved in DNA replication and transcription resulting in inhibition of DNA, RNA, and protein synthesis, leading ultimately to cell death [2].”
Background
Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity
Ferreira, A., Cunha‐Oliveira, T., Simões, R. F., Carvalho, F. S., Burgeiro, A., Nordgren, K. K. S., Wallace, K. B., & Oliveira, P. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.08.011 · Cited by 78
“Administration of DOX commonly results in readily reversible short-term acute effects such as nausea, diarrhea, alopecia and electrocardiography alterations (Carvalho et al., 2009; Sterba et al., 2013).”
BackgroundSelf-citation
Nucleosome-inspired nanocarrier obtains encapsulation efficiency enhancement and side effects reduction in chemotherapy by using fullerenol assembled with doxorubicin
Tang, J., Zhang, R., Guo, M., Shao, L., Liu, Y., Zhao, Y., Zhang, S., Wu, Y. F., & Chen, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.015 · Cited by 77
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Eptaminitaki, G. C., Stellas, D., Bonavida, B., & Baritaki, S. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100866 · Cited by 78
A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market
Gonçalves, M., Mignani, S. M., Rodrigues, J., & Tomás, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.016 · Cited by 76
Therapeutic targeting of the functionally elusive TAM receptor family
Miao, Y. R., Rankin, E. B., & Giaccia, A. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00846-8 · Cited by 88
Monitoring doxorubicin cellular uptake and trafficking using in vitro Raman microspectroscopy: short and long time exposure effects on lung cancer cell lines
Farhane, Z., Bonnier, F., & Byrne, H. J. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-0065-0 · Cited by 74
“high lipophilicity, binds to proteasomal then translocates into the nuclear area,via nuclear pores, where it dissociates from the proteasome complex and binds to DNA with hight affinity, (1, 7) a larger amount accumulating in the denser nucleolar area, which saturates more rapidly.”
Background
Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery
Hefnawy, A., Khalil, I. A. H., Arafa, K. K., Emara, M., & El-sherbiny, I. M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s240359 · Cited by 74
“Moreover, damaging the kidneys affects the whole body due to its major role in regulating the composition of blood and other body fluids.(41) The results of the histopathological examination showed that our developed targeted formula loaded with DOX was safer than the conventional DOX.”
Background
Hyaluronic acid-modified, IR780-conjugated and doxorubicin-loaded reduced graphene oxide for targeted cancer chemo/photothermal/photodynamic therapy
Dash, B. S., Lu, Y., Pejrprim, P., et al. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212764 · Cited by 72
Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles
Prados, J. C., Cabeza, L., Ortíz, R., Arias, J. L., Adolfina, M. A., Entrena, J. M., Luque, R., & Melguizo, C. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s74378 · Cited by 71
“However, DOX-based chemotherapy is characterized by poor tumor selectivity plus severe (dose-limiting) side effects in healthy tissues and cells.(3,4) Furthermore, DOX can lead to drug resistance in breast cancer cells, which may be another pertinent cause of chemotherapy failure.”
An overview on the delivery of antitumor drug doxorubicin by carrier proteins
Agudelo, D., Bérubé, G., & Tajmir‐Riahi, H. A. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.03.060 · Cited by 72
Dimerization of Doxorubicin Causes Its Precipitation
Yamada, Y. (2020) · ACS Omega · doi:10.1021/acsomega.0c04925 · Cited by 72
Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies
Khalifa, M. M., Al-Karmalawy, A. A., Elkaeed, E. B., et al. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.2007905 · Cited by 71
HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles
Alhareth, K., Vauthier, C., Gueutin, C., et al. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.01.025 · Cited by 71
Preventive Effects of Ellagic Acid Against Doxorubicin-Induced Cardio-Toxicity in Mice
Lin, M., & Yin, M. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9197-z · Cited by 71
Comprehensive exploration of the anticancer activities of procaine and its binding with calf thymus DNA: a multi spectroscopic and molecular modelling study
Ali, M. S., Farah, M. A., Al‐Lohedan, H. A., & Al‐Anazi, K. M. (2018) · RSC Advances · doi:10.1039/c7ra13647a · Cited by 70
Improved cardioprotective effects of hesperidin solid lipid nanoparticles prepared by supercritical antisolvent technology
Saad, S., Ahmad, I., Kawish, S. M., et al. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110628 · Cited by 70
Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling
Zhang, J., Wang, M., Ding, W., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114188 · Cited by 70
Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity
Lages, E. B., Fernandes, R. S., Silva, J. D. O., Malachias, Â., Cassali, G. D., de Barros, A. L. B., & Ferreira, L. A. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110876 · Cited by 71
Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
Liu, X., Zhang, Y., Wu, X., Xu, F., Ma, H., Wu, M., & Xia, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.909821 · Cited by 78
Protective effects of fish omega-3 fatty acids on doxorubicin-induced testicular apoptosis and oxidative damage in rats
Uygur, R., Aktaş, C., Tulubas, F., et al. (2013) · Andrologia · doi:10.1111/and.12173 · Cited by 70
“However, © 2013 Blackwell Verlag GmbH 917 Andrologia 2014, 46, 917–926 oxidative stress and the production of reactive oxygen species (ROS) are involved in DOX damage (Carvalho et al., 2009).”
Background
Efficient Delivery of DOX to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using pH-Sensitive Pullulan–DOX Conjugates
Li, H., Cui, Y., Sui, J., Bian, S., Sun, Y., Liang, J., Fan, Y., & Zhang, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b03150 · Cited by 70
Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma
Chen, J., Dai, Q., Yang, Q., Bao, X., Zhou, Y., Zhong, H., Wu, L., Wang, T., Zhang, Z., Lu, Y., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01304-0 · Cited by 68
“The intracellular transport pathway of DOX is closely related to proteasome action [13, 14], the latter entering the nucleus through the NLS structure [15].”
Background
Liposome–Hydrogel Composites for Controlled Drug Delivery Applications
Binaymotlagh, R., Haghighi, F. H., Chronopoulou, L., & Palocci, C. (2024) · Gels · doi:10.3390/gels10040284 · Cited by 77
“Despite its therapeutic applications, the clinical use of Dox is restricted by its dose-limiting toxicity, resulting in cardiotoxic and myelosuppression side effects that increase cardiovascular risk [74].”
Background
Organoid Technology: Current Standing and Future Perspectives
Shariati, L., Esmaeili, Y., Javanmard, S. H., Bidram, E., & Amini, A. (2021) · Stem Cells · doi:10.1002/stem.3379 · Cited by 71
“The earliest application of CRISPR/Cas9 technology in 3D organoids, performed by Clevers research group, has been shown in the mutations and improving the chloride channel function of CF intestinal organoids derived from patients.(224) Moreover, many other studies have utilized”
Background
Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
Zhu, H., Luo, P., Fu, Y., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2410 · Cited by 68
“However, coming along with that, a serious adverse effect being life-threatening heart damage tempestuously limited its therapeutic potential [3, 4].”
Background
Early Outcomes for Malignant Peripheral Nerve Sheath Tumor Treated With Chemotherapy
Moretti, V. M., Crawford, E. A., Staddon, A. P., et al. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181e9c08a · Cited by 68
Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus
Kwatra, M., Jangra, A., Mishra, M., Sharma, Y., Ahmed, S., Ghosh, P., Kumar, V., Vohora, D., & Khanam, R. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1949-2 · Cited by 68
Protective effects of zinc oxide nanoparticles against doxorubicin induced testicular toxicity and DNA damage in male rats
ElMaddawy, Z., & Naby, W. S. H. A. E. (2019) · Toxicology Research · doi:10.1039/c9tx00052f · Cited by 68
Optimization of Mesoporous Silica Nanoparticles through Statistical Design of Experiment and the Application for the Anticancer Drug
Kim, M., Ki, D.-H., Na, Y., Lee, H.-S., Baek, J.-S., Lee, J., Lee, J., & Cho, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020184 · Cited by 69
“Despite the advantages associated with DOX, there are obvious problems with side effects [18].”
Background
Animal models of chemotherapy-induced cognitive decline in preclinical drug development
John, J., Kinra, M., Mudgal, J., Viswanatha, G. L., & Nandakumar, K. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05977-7 · Cited by 73
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
Tacar, O., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12144 · Cited by 67
“This process occurs as Dox enters the cell through diffusion using its higher affinity to bind to the proteasome in the cytoplasm.([24]) A Dox–proteasome complex is formed when Dox binds to the 20S subunit of the proteosome, whereby it is then translocated through the nuclear pores into the nucleus.”
Background
Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug
Huang, S., Fang, R. M., Xu, J., Qiu, S., Zhang, H., Du, J., & Cai, S. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2010.511225 · Cited by 67
“In spite of the potent antitumor activity, Dox is usually restricted in clinical application because of the severe toxicities to normal tissues, especially the heart (Zhou et al., 2001; Carvalho et al., 2009).”
Background
99mTc-doxorubicin-loaded gallic acid-gold nanoparticles (99mTc-DOX-loaded GA-Au NPs) as a multifunctional theranostic agent
El-Ghareb, W. I., Swidan, M. M., Ibrahim, I. T., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119514 · Cited by 66
Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy
Fuente, A. D. L., Zilio, S., Caroli, J., Simaeys, D. V., Mazza, E. M. C., Ince, T. A., Bronte, V., Bicciato, S., Weed, D. T., & Serafini, P. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aav9760 · Cited by 67
“However, these treatments are associated with moderate to serious toxicities that decrease the overall quality-of-life for patients with cancer and are thus often dose limiting and responsible for modest therapeutic efficacy (1, 2).”
Background
Targeting OCT3 attenuates doxorubicin-induced cardiac injury
Huang, K. M., Thomas, M. Z., Magdy, T., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020168118 · Cited by 66
“T anthracycline doxorubicin is commonly used in many regimens for the treatment of solid tumors and hematological malignancies (1, 2).”
Background
Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells
Khalili‐Tanha, G., & Moghbeli, M. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00282-9 · Cited by 68
“It has toxic effects on normal heart, brain, kidney and liver tissues [7].”
Background
Chemotherapy stimulates syndecan-1 shedding: A potentially negative effect of treatment that may promote tumor relapse
Ramani, V. C., & Sanderson, R. D. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.10.005 · Cited by 66
“Bort and Dox are drugs belonging to entirely different families of therapeutic agents and mediate tumor cell killing via distinct mechanisms (Carvalho et al., 2009; Paramore and Frantz, 2003).”
Background
Conventional Chemotherapy Nephrotoxicity
Gupta, S., Portales‐Castillo, I., Daher, A., et al. (2021) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2021.08.001 · Cited by 65
Bioinspired phospholipid polymer prodrug as a pH-responsive drug delivery system for cancer therapy
Wang, H., Xu, F., Li, D., et al. (2013) · Polymer Chemistry · doi:10.1039/c2py20981k · Cited by 65
A pH and magnetic dual-response hydrogel for synergistic chemo-magnetic hyperthermia tumor therapy
Zhou, X., Wang, L., Xu, Y., Du, W., Cai, X., Wang, F., Ling, Y., Chen, H., Wang, Z., Hu, B. Q., et al. (2018) · RSC Advances · doi:10.1039/c8ra00215k · Cited by 66
Effects of Selected Metal Nanoparticles (Ag, ZnO, TiO2) on the Structure and Function of Reproductive Organs
Dianová, L., Tirpák, F., Halo, M., et al. (2022) · Toxics · doi:10.3390/toxics10080459 · Cited by 64
Green Preparation Process, Characterization and Antitumor Effects of Doxorubicin–BSA–Dextran Nanoparticles
Deng, W., Li, J., Yao, P., He, F., & Huang, C. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.201000125 · Cited by 65
α-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles
Oliveira, M. S., Mussi, S. V., Gomes, D. A., Yoshida, M. I., Frézard, F., Carregal, V. M., & Ferreira, L. A. M. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.019 · Cited by 65
Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere
Campelj, D. G., Goodman, C. A., & Rybalka, E. (2021) · Cancers · doi:10.3390/cancers13143615 · Cited by 72
Protective Effect of Lycium barbarum Polysaccharides Against Doxorubicin‐induced Testicular Toxicity in Rats
Xin, Y., You, Z., Gao, H., et al. (2011) · Phytotherapy Research · doi:10.1002/ptr.3633 · Cited by 63
Self-Assembling Polymer Micelle/Clay Nanodisk/Doxorubicin Hybrid Injectable Gels for Safe and Efficient Focal Treatment of Cancer
Nagahama, K., Kawano, D., Oyama, N., Takemoto, A., Kumano, T., & Kawakami, J. (2015) · Biomacromolecules · doi:10.1021/bm5017805 · Cited by 64
Nanopore Single-Molecule Analysis of DNA–Doxorubicin Interactions
Yao, F., Duan, J., Wang, Y., et al. (2014) · Analytical Chemistry · doi:10.1021/ac503926g · Cited by 63
Doxorubicin cardiomyopathy is ameliorated by acacetin via Sirt1‐mediated activation of AMPK/Nrf2 signal molecules
Wu, W., Cui, Y., Hong, Y., Li, Y., Wu, Y., Li, G., Li, G., & Wang, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15859 · Cited by 62
Nanocarrier design–function relationship: The prodigious role of properties in regulating biocompatibility for drug delivery applications
Oladipo, A. O., Lebelo, S. L., & Msagati, T. A. M. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110466 · Cited by 65
Esculetin improves inflammation of the kidney via gene expression against doxorubicin-induced nephrotoxicity in rats: In vivo and in silico studies
Karağaç, M. S., Yeşilkent, E. N., Kizir, D., Öztürk, N., Isıyel, M., Karadaş, H., Tosun, H., Karaman, M., Ceylan, H., & Demir, Y. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105159 · Cited by 66

Authors: Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P.
Affiliations: Centro de Neurociências e Biologia Celular (PT)
Corresponding author: Moreira, Paula
ORCID: Carvalho, Cristina
Santos, Renato
Cardoso, Susana
Oliveira, Paulo
Santos, Maria
Moreira, Paula
Venue: Current Medicinal Chemistry
Publisher: Bentham Science Publishers Ltd.
Published: 2009-09-01
Volume: 16
Issue: 25
Pages: 3267-3285
ISSN: 0929-8673 (ISSN-L)
DOI: 10.2174/092986709788803312
OpenAlex: W2102897174
Cited by: 1,509
References: 0
Citations by year: 2026: 102 · 2025: 147 · 2024: 174 · 2023: 169 · 2022: 153 · 2021: 150 · 2020: 120 · 2019: 85 · 2018: 84 · 2017: 53 · 2016: 63 · 2015: 62 · 2014: 43 · 2013: 35 · 2012: 29
FWCI: 14.12
Type: journal article
Language: en
Open access: closed
Locations: Current Medicinal Chemistry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords: doxorubicin, anthracyclines, cardiotoxicity, drug toxicity mechanisms, anticancer mechanism, neurotoxicity, nephrotoxicity, hepatotoxicity, chemotherapy side effects
MeSH terms: Antibiotics, Antineoplastic, Doxorubicin, Humans, Molecular Conformation, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Doxorubicin: The Good, the Bad and the Ugly Effect

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks